Adverum Biotechnologies Inc (ADVM) Beta: Monthly Comparison and Analysis

Adverum Biotechnologies Inc (NASDAQ: ADVM) closed the day trading at $12.01 down -4.53% from the previous closing price of $12.58. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 511262 shares were traded.

Ratios:

For a better understanding of ADVM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.13 and its Current Ratio is at 4.13. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.77.

SVB Leerink Downgraded its Outperform to Mkt Perform on May 03, 2021, while the target price for the stock was maintained at $5.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 07 ’24 when Lupher, Jr. Mark L. bought 130,000 shares for $1.35 per share. The transaction valued at 175,500 led to the insider holds 130,000 shares of the business.

Scopa James Paul bought 100,000 shares of ADVM for $135,000 on Feb 07 ’24. The Director now owns 100,000 shares after completing the transaction at $1.35 per share. On Sep 15 ’23, another insider, Seyedkazemi Setareh, who serves as the Chief Development Officer of the company, sold 6,201 shares for $1.52 each. As a result, the insider received 9,429 and left with 47,674 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADVM now has a Market Capitalization of 249.45M and an Enterprise Value of 227.96M. For the stock, the TTM Price-to-Sale (P/S) ratio is 69.22 while its Price-to-Book (P/B) ratio in mrq is 1.46. Its current Enterprise Value per Revenue stands at 63.32 whereas that against EBITDA is -1.93.

Stock Price History:

Over the past 52 weeks, ADVM has reached a high of $29.70, while it has fallen to a 52-week low of $6.81. The 50-Day Moving Average of the stock is 17.25, while the 200-Day Moving Average is calculated to be 14.07.

Shares Statistics:

Over the past 3-months, ADVM traded about 260.63K shares per day on average, while over the past 10 days, ADVM traded about 253.67k shares per day. A total of 20.75M shares are outstanding, with a floating share count of 14.97M. Insiders hold about 27.90% of the company’s shares, while institutions hold 33.27% stake in the company. Shares short for ADVM as of Mar 15, 2024 were 648.48k with a Short Ratio of 2.49, compared to 400.94k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.12% and a Short% of Float of 3.25%.

Earnings Estimates

Current recommendations for the stock of the company come from 5 analysts. On average, analysts expect EPS of -$1.41 for the current quarter, with a high estimate of -$1.2 and a low estimate of -$1.91, while EPS last year was -$2.9. The consensus estimate for the next quarter is -$1.31, with high estimates of -$1.2 and low estimates of -$1.48.

Analysts are recommending an EPS of between -$4.8 and -$6.01 for the fiscal current year, implying an average EPS of -$5.41. EPS for the following year is -$5.43, with 5 analysts recommending between -$4.9 and -$6.

Most Popular

[the_ad id="945"]